TrialNCT07641517
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
- Status
- RECRUITING
- Phase
- PHASE2
- Last update posted
- 09/04/2026
- Start
- 06/25/2026
- Sponsor
- Eli Lilly and Company
- Specialties
- orthopaedics
Conditions: Osteoarthritis, Knee; Chronic Pain
Brief summary
The main purpose of this study is to test the safety and efficacy of study drug for the treatment of knee pain due to osteoarthritis (OA). This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292), which is a protocol to accelerate the development of new treatments for chronic pain.
Protocol documents and results are not hosted here. Verify every detail on ClinicalTrials.gov.